Company / Depreciation & Amortization
Xenetic Biosciences, Inc. Depreciation & Amortization History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
-
FY2022
5-year range
$0 / $1.0K
FY2018-FY2022
Trend
-100.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $4,199 to $0 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Xenetic Biosciences, Inc.'s depreciation & amortization has declined for 6 consecutive years.
- In FY2022, depreciation & amortization decreased 100.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $1.0K | -76.2% |
| FY2020 | $4.2K | -73.5% |
| FY2019 | $15.8K | -33.5% |
| FY2018 | $23.8K | -34.7% |
| FY2017 | $36.4K | -35.0% |
| FY2016 | $56.1K | +7.8% |
As of FY2022 · SEC 10-K Annual Filings · Last checked Jun 28, 2026